Protalix Biotherapeutics Inc. buy melinda
Start price
17.05.17
/
50%
€7.24
Target price
25.05.17
€9.00
Performance (%)
12.85%
End price
25.05.17
€8.17
Summary
This prediction ended on 25.05.17 with a price of €8.17. The prediction had a final performance of 12.85%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Protalix Biotherapeutics Inc. | 4.167% | 4.167% | -13.018% | 33.869% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% | 65.510% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% | 95.368% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% | 42.232% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% | 59.132% |
Comments by melinda for this prediction
In the thread Protalix Biotherapeutics Inc. diskutieren
Gesundheit | Biotechnologie | Israel
Stopped prediction by melinda for Protalix Biotherapeutics Inc.
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€1.63
27.12.23
27.12.23
€2.00
27.12.24
27.12.24
9.02%
28.12.24
28.12.24
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€6.96
02.06.16
02.06.16
€12.00
02.12.16
02.12.16
-22.13%
02.12.16
02.12.16
Protalix Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€32.52
23.09.13
23.09.13
€40.00
24.03.14
24.03.14
2.15%
24.03.14
24.03.14